189 related articles for article (PubMed ID: 25250818)
1. Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.
Fan YN; Meley D; Pizer B; Sée V
PLoS One; 2014; 9(9):e108514. PubMed ID: 25250818
[TBL] [Abstract][Full Text] [Related]
2. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
Weeraratne SD; Amani V; Neiss A; Teider N; Scott DK; Pomeroy SL; Cho YJ
Neuro Oncol; 2011 Feb; 13(2):165-75. PubMed ID: 21177782
[TBL] [Abstract][Full Text] [Related]
3. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
9. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
10. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
[TBL] [Abstract][Full Text] [Related]
12. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
[TBL] [Abstract][Full Text] [Related]
14. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
15. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
[TBL] [Abstract][Full Text] [Related]
17. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
20. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
